Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. lymphodrain

LymphoDrain SIGNED

LymphoDrain: The definitive solution for chronic lymphedema

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LymphoDrain project word cloud

Explore the words cloud of the LymphoDrain project. It provides you a very rough idea of what is the project "LymphoDrain" about.

skin    device    worldwide    tissues    externally    physiotherapy    convert    patient    vessels    disorder    replaces    social    acute    cure    implant    reducing    innovative    immobility    subcutaneous    economy    solution    consists    therapies    disability    procedure    care    treat    population    lymphatica    causing    fluid    disorders    restore    effect    urgent    billion    impairments    creates    drainage    compression    lymph    draining    treatments    additional    bills    chronic    genetic    function    garments    grow    expectancy    financial    injury    invasive    constant    pump    welfare    first    despite    limbs    lymphatic    le    disease    risk    disfunction    continuous    wearable    live    obesity    physiological    caused    4    valued    secondary    prevalence    earnings    arise    venous    implanted    incapacity    ages    lymphedema    daily    definitive    closely    million    lymphodrain    global    resolution    life    clear    constantly    country    healthcare    trauma    productive    flow    minimally    occurrence    catheter    health    pain    producing    micro    complications    cancer    accumulation    normal    becomes    infections    832    patients   

Project "LymphoDrain" data sheet

The following table provides information about the project.

Coordinator		 LYMPHATICA MEDTECH SA 

Organization address
address: BATIMENT E EPFL INNOVATION PARK
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Switzerland [CH]
 Total cost 2˙586˙750 €
 EC max contribution 1˙810˙725 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2022-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LYMPHATICA MEDTECH SA CH (LAUSANNE) coordinator 1˙810˙725.00

Map

 Project objective

Lymphedema (LE) is a chronic disfunction of the lymphatic system causing fluid accumulation in the limbs, which affects more than 100 million patients worldwide. Its occurrence is closely related to cancer, being a very common side effect of cancer therapies, but can also arise from genetic disorders or due to injury, trauma, venous disorders, obesity, immobility, etc. Despite recent advances, at present there is no cure for LE which becomes a chronic disorder. The disease must be treated constantly by the patient, to avoid complications, with daily use of compression garments, physiotherapy and skin care. Thus, it creates a constant disability for the patient and, more importantly, it affects his/her ability to work and to live a normal life. In Europe, the financial impact of LE is valued at around €832 million in health and social welfare bills, with an additional €2.3 billion used to treat infections secondary to LE, as well as an additional €4.4 billion in loss of earnings as a result of productive incapacity of the patients. In addition, the prevalence of chronic LE is expected to grow as the life expectancy increases and the global population ages. There is an urgent need for innovative approaches to restore continuous lymph flow drainage in affected tissues, producing a definitive solution for LE. Lymphatica´s subcutaneous implant, LymphoDrain, consists of a draining catheter and a micro-pump externally controlled by a wearable device, and replaces the function of lymphatic vessels. It is implanted via a minimally invasive procedure, and results in the resolution of the physiological impairments caused by LE reducing pain, the risk of potential complications and the need for additional treatments. Lymphatica´s goal is to convert LymphoDrain in the first definitive solution for LE patients and a clear solution for reducing the impact of LE on both the healthcare system and the economy of each country.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYMPHODRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYMPHODRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

PRIVATETRACK (2019)

PRIVATETRACK: Privacy-friendly, low-power intelligent room occupancy detection and people counting.

Read More  

AUTHEVOO (2019)

DNA-Authenticity & Traceability for Extra Virgin Olive Oil: Τrust the DNA, the label.

Read More